Eric Dobmeier

Affiliations

  • at Janux Therapeutics Inc. (JANX), 2024-07-25
  • at Structure Therapeutics Inc. (GPCR), 2024-06-27
  • at Atara Biotherapeutics Inc. (ATRA), 2023-11-14
  • President, Ceo at Chinook Therapeutics Inc. (KDNY), 2023-08-11
  • Director at Adaptive Biotechnologies Corp (ADPT), 2021-02-18
  • Director at Versartis Inc. (VSAR), 2017-12-22
  • Chief Operating Officer at Seattle Genetics Inc (SGEN), 2017-12-07
  • Director at Stemline Therapeutics Inc (STML), 2017-06-20
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ATRA $0.23 446,825 563,325 2023-11-10 Filing
KDNY $13.03 5,000 Officer, Director 205,880 2022-05-25 Filing
KDNY $12.00 2,000 Officer, Director 109,837 2021-09-20 Filing
KDNY $12.00 3,000 Officer, Director 107,837 2021-08-19 Filing
KDNY $11.74 7,000 Officer, Director 104,837 2021-08-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KDNY $22.26 1,200 Officer, Director 301,138 2023-04-24 Filing
KDNY $21.58 23,800 Officer, Director 302,338 2023-04-24 Filing
KDNY $23.75 8,097 Officer, Director 301,138 2023-02-10 Filing
KDNY $24.68 7,688 Officer, Director 288,987 2023-01-31 Filing
KDNY $24.54 25,000 Officer, Director 271,676 2023-01-30 Filing